Jeffrey Slaiby, MD
Vascular Surgery · Providence, RINPI 1821096777
Payments from drug & device makers
What this record shows
W. L. Gore & Associates, Inc. accounts for 84.3% of it on its own, with 7 other manufacturers making up the rest.
Across 45 payments — averaging $117.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Getinge USA Sales, LLC$202
- Penumbra, Inc.$150
- Endologix LLC$147
- Silk Road Medical, Inc.$146
- Cook Medical LLC$136
- plus $50 from 2 others
Across 1 payment — averaging $44,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$45K
What the payments were for
- Travel & lodging$2,14341%
- Food & beverage$3,14559%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 32 | $4,457 |
| Getinge USA Sales, LLC | 5 | $202 |
| Penumbra, Inc. | 1 | $150 |
| Endologix LLC | 2 | $147 |
| Silk Road Medical, Inc. | 1 | $146 |
| Cook Medical LLC | 2 | $136 |
| Intact Vascular, Inc. | 1 | $31 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Thoracic Endoprosthesis$1,314
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$926
- GORE TAG Conformable Thoracic Endoprosthesis$749
- EXCLUDER AAA Endoprosthesis$498
- ENROUTE Transcarotid Neuroprotection System$292
- Indigo$150
- ENROUTE Transcarotid Stent$146
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$146
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$143
- GORE TAG Thoracic Branch Endoprosthesis$139
- Ovation$133
- AFX$133
- GORE VIABAHN VBX Balloon Expandable Endo$133
- ROSEN$109
How this compares
Too few vascular surgery providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 16 | $12,887 |
| Cilostazol | 282 | $5,693 |
| BrilintaTicagrelor | 11 | $4,904 |
| Pentoxifylline | 106 | $4,022 |
| ClopidogrelClopidogrel Bisulfate | 41 | $575 |
| Ammonium Lactate | 12 | $404 |
| Atorvastatin Calcium | 15 | $155 |
| Oxycodone Hcl | 20 | $85 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Providence
- Junaid MalekProvidence$14K
- Lars StangenbergProvidence$12K
- Katherine MaccallumProvidence$8K
- Peter SodenProvidence$7K
- Carla MoreiraProvidence$5K
- Edward MarcaccioProvidence$2K
- Thomas CarruthersProvidence$976
- Robert PattersonProvidence$850
- Richard MeenaProvidence$754
- Tze Tec ChongProvidence$208
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.